Menu Search
Equities

As One Corp

7476:TYO

As One Corp

Actions
Health CareMedical Equipment and Services
  • Price (JPY)2,760.50
  • Today's Change-12.50 / -0.45%
  • Shares traded71.10k
  • 1 Year change+10.53%
  • Beta1.1151
Data delayed at least 20 minutes, as of Nov 15 2024 06:30 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Forecasts data is unavailable for this security.

Consensus recommendation

  • 16-Nov-23
  • 15-Aug-24
  • 19-Sep-24
  • 17-Oct-24
  • 07-Nov-24
Select bar for recommendation details.
Recommendations07-Nov-24
Buy1
Outperform2
Hold0
Sell0
Strong Sell0

Share price forecast in JPY

The 3 analysts offering 12 month price targets for As One Corp have a median target of 3,700.00, with a high estimate of 3,800.00 and a low estimate of 3,500.00. The median estimate represents a 34.03% increase from the last price of 2,760.50.
High37.7%3,800.00
Med34.0%3,700.00
Low26.8%3,500.00

Dividends in JPY

In 2024, As One Corp reported a dividend of 56.00 JPY, which represents a 0.90% increase over last year. The 2 analysts covering the company expect dividends of 57.00 JPY for the upcoming fiscal year, an increase of 1.79%.
Div growth (TTM)0.90%
More ▼

Earnings history & estimates in JPY

As One Corp reported annual 2024 earnings of 103.65 per share on May 14, 2024.
Average growth rate+7.21%
More ▼

Revenue history & estimates in JPY

AS ONE Corporation had 2nd quarter 2025 revenues of 24.46m. This missed the 24.65m consensus estimate of the 2 analysts following the company. This was 12.53% above the prior year's 2nd quarter results.
Average growth rate+2.58%
AS ONE Corporation had revenues for the full year 2024 of 95.54m. This was 4.50% above the prior year's results.
Average growth rate+8.03%
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.